VR Logo

Athersys Inc. (ATHX) download report


Healthcare | Biotechnology & Pharma Research

Athersys Inc. (ATHX) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine.

IPO Date: 12-Jun-2007

Co-Founder, Chief Scientific Officer, Exec. VP & Director: Dr. John J. Harrington Ph.D.

Chief Financial Officer & Principal Accounting Officer: Mr. Ivor Macleod CPA, M.B.A.

Listing: NASDAQ: ATHX

Country: United States

Headquarters: Cleveland, OH

Website: https://www.athersys.com

Key Facts

Market cap: $73.83 Mln

Revenue (TTM): $2.91 Mln

Earnings (TTM): $-82.70 Mln

Cash: $21.80 Mln

Total Debt: $9.52 Mln

Insider's Holding: 7.50%

Liquidity: Low

52 Week range: $0.18 - 1.81

Shares outstanding: 258,068,992

10 Years Aggregate:

  • CFO: $-301.62 Mln
  • EBITDA: $-269.78 Mln
  • Net Profit: $-366.15 Mln

Stock Performance

Time Period Athersys (ATHX) S&P BSE Sensex S&P Small-Cap 600
YTD-71.11-9.18-18.78
1 month23.81-4.78-8.00
3 months-57.38-9.66-13.65
1 Year-81.940.81-17.19
3 Years-46.3110.336.10
5 Years-29.6611.345.87
10 Years-16.6711.749.84
As on 01-Jul-2022
Year Athersys (ATHX) S&P Small-Cap 600 S&P BSE Sensex
2021-48.5725.2721.99
202042.289.5715.75
2019-14.5820.8614.38
2018-20.34-9.705.87
201718.3011.7327.91
201648.5424.741.95
2015-34.81-3.36-5.03